MEDX:NSD-Horizon Kinetics Medical ETF (USD)

ETF | Others |

Last Closing

USD 26.4254

Change

+0.25 (+0.94)%

Market Cap

N/A

Volume

44.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

-1.77 (-2.97%)

USD 65.59B
QQQM Invesco NASDAQ 100 ETF

-1.66 (-0.76%)

USD 46.74B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.19 (-0.36%)

USD 25.59B
ACWI iShares MSCI ACWI ETF

-0.37 (-0.30%)

USD 21.43B
CGABL The Carlyle Group Inc. 4.625% ..

-0.01 (-0.06%)

USD 16.14B
TSLL Direxion Shares ETF Trust - Di..

-3.91 (-28.50%)

USD 6.20B
TBIL Rbb Fund Inc - Us Treasury 3 M..

N/A

USD 5.83B
ETHA iShares Ethereum Trust ETF

-0.73 (-3.67%)

USD 3.58B
NVDL GraniteShares 1.5x Long NVDA D..

-1.57 (-2.73%)

USD 3.52B
MAGS Roundhill Magnificent Seven ET..

-1.39 (-2.63%)

USD 2.32B

ETFs Containing MEDX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.13% 52% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.13% 49% F 61% D-
Trailing 12 Months  
Capital Gain -9.53% 21% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.53% 20% F 41% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -1.20% 32% F 40% F
Dividend Return -1.20% 25% F 36% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 4.09% 80% B- 95% A
Risk Adjusted Return -29.36% 19% F 23% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector